Onechaintx
1 known investors
OneChain Immunotherapeutics is a clinical-stage biotech developing CAR-T cell therapy candidates as treatments for oncological diseases. It is a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team.
Founders & leadership
PM
Pablo MenéndezScientific Founder
Investors · 1
Frequently asked questions
- What does Onechaintx do?
- OneChain Immunotherapeutics is a clinical-stage biotech developing CAR-T cell therapy candidates as treatments for oncological diseases. It is a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team.
- Who founded Onechaintx?
- Onechaintx was founded by Pablo Menéndez.
- Who are Onechaintx's investors?
- Onechaintx's investors include Invivo Capital Partners.